Skip to content

NMN in Germany and the EU

NMN and EU Novel Food rules, in plain language: what you can buy, what you can't, and what it actually means for you.

Updated · 10 min read

The short answer

As of September 2026, NMN may not be sold as a food supplement in Germany or anywhere in the EU. It is a novel food, and it has no EU authorisation yet [1]. On 11 May 2026, EFSA published a positive safety opinion on EffePharm's NMN, which the company markets as Uthever®: up to 300 mg a day is safe for adults, excluding pregnant and breastfeeding women [7]. The European Commission has not adopted an authorisation yet. It has seven months from the opinion to put a draft to the Member States, so until about December 2026 [1]. Their vote and publication can take longer. The authorisation will apply to that specific product, not NMN in general. Want a legally sold NAD+ precursor today? Nicotinamide riboside (NR) has been EU-authorised as a novel food since 2020 [2].

This content is for educational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional before making changes to your diet, exercise routine, or supplement regimen.

What is NMN?

Nicotinamide mononucleotide (NMN) is a small molecule your body uses to build NAD+ (nicotinamide adenine dinucleotide, the coenzyme every cell needs to run its metabolism). NAD+ levels drop as you get older. That single fact grew into a whole supplement trend.

The pitch is simple. Top up NAD+ from the outside, and you slow down some parts of aging. Harvard's David Sinclair is the loudest voice behind it. The human evidence is still thin. A small 2021 trial in Science (Yoshino) gave 250 mg of NMN a day for 10 weeks to postmenopausal women with prediabetes and overweight or obesity. Their muscle insulin sensitivity improved [5]. A 2022 study in npj Aging (Igarashi) found that 250 mg a day raised blood NAD+ in older men. Gait speed and left-hand grip improved only nominally, and the authors say that needs checking in larger studies [6]. That is mechanism evidence. It does not show a longer life.

Want the science of NMN? See our longevity supplements guide. This guide is only about the legal picture in Germany and the EU. No dosing advice, only the EU safety limit. Not where to buy. Not medical use. The goal here is to help you read a confusing rulebook before you spend money on something that may not be legal to sell where you live.

Is NMN banned in the EU? (status September 2026)

Short answer: yes, for now. NMN is a novel food without EU authorisation, so it may not be sold as food or a food supplement anywhere in the EU [1]. One product is close. On 11 May 2026 EFSA published a positive safety opinion on EffePharm's NMN, which the company markets as Uthever® [7]. As of late September 2026, the European Commission has not adopted the authorisation yet.

The EU Novel Food regulation (Regulation (EU) 2015/2283) decides which ingredients can be sold as food or supplements anywhere in the EU [1]. An ingredient counts as "novel" if Europeans did not eat it in any meaningful amount before 15 May 1997. Anything novel needs authorisation before it can legally hit shelves.

Where NMN actually stands:

  • The EU novel food catalogue lists NMN as a novel food. It needs authorisation before it can be sold legally as a supplement anywhere in the bloc.
  • On 11 May 2026, EFSA published a positive safety opinion on EffePharm's NMN. The verdict: up to 300 mg per day is safe for adults, excluding pregnant and breastfeeding women [7].
  • The safety verdict has limits. In a 90-day rat study, the highest dose caused changes in reproductive organs. The highest dose without adverse effects was 400 mg per kg of body weight a day. EFSA judged that margin sufficient for 300 mg a day in adults. Higher intakes were not assessed [7].
  • The European Commission and the Member States still have to adopt the actual authorisation. The Commission has seven months from the EFSA opinion to put a draft authorisation to the Member States, so until about December 2026 [1]. Their vote and publication can take longer. When it lands, the authorisation will be product-specific to EffePharm. So generic NMN from other producers stays under Novel Food restrictions until each applicant earns its own positive opinion and Commission authorisation.

Other countries:

  • USA: The FDA pulled NMN from the dietary supplement category in late 2022, because of a parallel pharmaceutical filing for the same molecule. Then citizen petitions came in from the Natural Products Association and the Alliance for Natural Health. On 29 September 2025 the FDA issued a response letter that set aside its 2022 superseding letter and put NMN back inside the dietary supplement definition [4]. A regulatory reversal, not a court ruling.
  • Japan and parts of Asia: NMN is widely available and openly sold.
  • Switzerland: Outside the EU, so its own rules apply.

What this means at the till. Products marketed in Germany as "NMN supplements" are sold without the authorisation EU food law requires [1]. Many shops label NMN as "laboratory chemical" or "for research use only." That label does not turn it into an authorised food. It only means nobody has cleared it for you to swallow.

The German-speaking market (DACH: Germany, Austria, Switzerland) in practice. Some online shops in these countries sell NMN anyway. Many products ship from outside the EU, often from China, where EffePharm, the company behind the EFSA opinion above, is based.

Regional status table (September 2026):

Region Supplement status Rx / medicine Customs / import
Germany Not authorised, so sale as food is not allowed; EFSA positive safety opinion on EffePharm's NMN published 11 May 2026, Commission authorisation pending and product-specific [1, 7] Not approved EU-internal: no issue
Austria Same as Germany (EU rules apply) Not approved EU-internal: no issue
Switzerland Outside EU Novel Food regime; Swissmedic and BLV have their own process Swissmedic regulates medicines Check current BLV status before ordering
USA Lawful as dietary supplement since 29 Sept 2025 FDA amendment Not approved as drug Ships freely within US
China Not approved as food or health food on the mainland. NHC, China's health regulator, rejected NMN as a food additive in May 2023. It is not approved as a new food raw material either. Several cross-border e-commerce platforms stopped selling imported NMN in 2024. China is still a major NMN producer and exporter N/A Customs interception possible for EU buyers
Japan Widely sold, openly marketed Not approved as drug Legal export; EU import still bound by EU Novel Food rules

Can you still buy NMN in Germany?

In practice, you can still find NMN online in Germany. But no shop may sell it as food, no doctor can prescribe it, quality is unverified, and any concrete health claim is illegal. Most of it is labelled "laboratory chemical," so the full responsibility for sourcing and safety lands on you. Four things are worth knowing before you order.

1. It is sold online anyway. NMN turns up on German and EU shops. It's usually labelled "laboratory chemical" or "research use only" to keep regulators at arm's length. Some shops in Germany, Austria and Switzerland offer it. Much of the stock comes from non-EU countries, often China. That is also where EffePharm sits, the company behind the EFSA application. Amazon has yanked NMN from its German marketplace and quietly put it back several times, depending on the legal read of the month.

2. A doctor cannot really prescribe it. NMN is not an approved medicine in Germany. So doctors cannot write the normal pink prescription (the Kassenrezept used for public health insurance) for it. Some private longevity clinics offer NAD+ infusions (a different substance in a different regulatory bucket) or point patients toward international suppliers. But the legal responsibility for what you put in your body lands squarely on you.

3. Quality and labelling are a coin flip. In a grey market, nobody is closely checking purity or labels. Independent tests by ConsumerLab.com have repeatedly found that the actual NMN inside the capsule can differ sharply from what the bottle promises on the front.

4. EU Health Claims Regulation (plus HWG). For a food supplement, the rule that bans slogans like "NMN rejuvenates cells" or "NMN extends life" is the EU Health Claims Regulation (Regulation (EC) No 1924/2006, called HCVO in Germany) [12]. It only allows health claims that are scientifically proven and on the EU's authorised list. Germany's Heilmittelwerbegesetz (HWG), the law on advertising medicines and treatments, stacks on top when the claim crosses into medicinal territory (for example "NMN prevents Alzheimer's") [3]. That is exactly why German sellers keep their product copy deliberately vague.

What about NR, niacinamide, and NAD+?

The legal alternative is nicotinamide riboside (NR), an NAD+ precursor that the EU authorised as a novel food in 2020, so it is sold legally in Germany [2]. Niacin and niacinamide (vitamin B3) are long approved and cheap, while NAD+ IV drips are a medical service only a doctor or Heilpraktiker may deliver. Each option carries a different legal status and evidence base.

NMN NR (nicotinamide riboside) Niacin / niacinamide (B3) NAD+ IV drip
EU status (September 2026) Not authorised; EFSA positive in May 2026, Commission decision pending [7] Authorised novel food since 2020 [2] Long authorised vitamin Medical service, not a food
EU daily limit in supplements None yet; EFSA judged 300 mg safe for adults [7] 300 mg for adults [2] National limits, no EU-wide cap Not applicable
Raises blood NAD+ in humans Yes [5, 6] Yes [8, 9] Yes, less targeted Yes, but evidence for lasting effects is thin
Hard longevity outcomes in humans None None None None

Nicotinamide riboside (NR). Another NAD+ precursor, and the easier of the two to discuss in public. The EU authorised NR as a novel food in 2020 under Commission Implementing Regulation 2020/16, which makes it legally sold in Germany [2]. The human trial record on NR is somewhat broader than the one on NMN. A 2016 study (Trammell) showed that NR doses up to 1,000 mg raise blood NAD+ in healthy adults [8]. A 2018 crossover trial in healthy middle-aged and older adults (Martens) gave 500 mg of NR twice daily for 6 weeks. It was well tolerated and raised NAD+. In a small exploratory subgroup with elevated or stage-1 blood pressure (n=13), systolic pressure was about 9 mmHg lower. That signal was not statistically significant. Treat it as a hypothesis to test, not a confirmed effect [9]. But a 2018 trial (Dollerup) was negative: 1,000 mg twice daily for 12 weeks did not improve insulin sensitivity in obese, insulin-resistant men [10]. So NAD+ goes up reliably. Whether that buys you years of healthspan is still wide open.

Where NMN and NR both stand. Both reliably raise NAD+ in blood. Neither has a large outcome trial. Most of the rejuvenation evidence comes from rodents or cell lines, some of them cancer cell lines, which is exactly where you do not want to push pro-growth signals. A 2024 study in Nature Medicine (Ferrell) adds one more caveat. High NAD+ turnover can raise 2PY and 4PY, two breakdown products left when the body clears excess vitamin B3. In observational data, both were linked to higher cardiovascular risk [11]. That is an association, not proof of harm. Caution is warranted with long-term mega-doses. NMN and NR are also broken down to nicotinamide in the end, so the caveat may apply to all NAD+ precursors at high doses. Still worth knowing before you commit a year of capsules to either molecule.

Niacin and niacinamide (vitamin B3). The original NAD+ building blocks. Long approved, and very cheap. Niacin causes the classic warm facial flush, and niacinamide does not. But both raise NAD+ less selectively than NR or NMN.

NAD+ IV drips. Some private clinics and Heilpraktiker offering longevity services provide NAD+ through a drip. Because it counts as a medical service, in Germany it must be delivered by a licensed doctor or a qualified Heilpraktiker under specific conditions. Evidence for lasting effects is thin, and sessions are expensive (usually 200 to 500 euros each).

Lifestyle levers that raise NAD+: exercise, eating fewer calories, and good sleep. All three are well supported by research. And they sit outside every regulatory question you might have.

How to spot a trustworthy NMN product

Before buying NMN, check six things. Where is the maker based? Is there an independent certificate of analysis showing ≥98% purity? How is the product labelled? What does a longevity-trained doctor advise? Are the promised effects realistic? And do you have a cancer history? Overblown longevity or disease claims are a quality red flag. They are also likely illegal under EU rules [12].

1. Where is the maker based? EU makers follow EU law. US and Asian makers do not. So if something goes wrong, recalls, liability, and quality control are much harder to enforce on products shipped from outside the bloc.

2. Is there an independent certificate of analysis (COA)? A serious maker is happy to hand over a COA from an independent lab. It should confirm both purity and actual NMN content, ideally by HPLC or qNMR.

3. How is the product labelled? "Dietary supplement" means the seller is using the regulated food channel. For NMN without novel food authorisation, that is not allowed [1]. "Research use only" or "not for human consumption" means the seller is sidestepping food law, and the responsibility shifts entirely to you.

4. What does your doctor say? For NAD+ questions, a doctor trained in preventive or functional medicine is usually a better sounding board than a general GP without that background. These practices are showing up in bigger German cities, mostly on a self-pay longevity basis.

5. Are the promised effects realistic? Serious sources talk about NAD+ levels and mechanisms. So if a product or seller promises concrete longevity, rejuvenation, or disease prevention, that likely breaches the EU Health Claims Regulation [12] (and the HWG if it is framed as medical treatment [3]). It's also a red flag about how careful the seller actually is.

6. A caution on cancer. If you have an active or recently treated cancer, caution is warranted here. Lab work on cancer cell lines points one way. NAMPT, the enzyme cells use to recycle NAD+, feeds the SASP (senescence-associated secretory phenotype): the inflammatory signals that worn-out, senescent cells release. In some tumour models, NAD+ metabolism also supports tumour metabolism. That is cell-line and mouse data, not proof of harm in humans. But it is enough for a caveat: use NMN or NR in cancer only in coordination with your oncology team.

What to look for on a NMN COA (Certificate of Analysis):

  • Batch / Lot number (matches the bottle you received)
  • Assay method: HPLC (liquid chromatography, which separates and measures each compound) or qNMR (quantitative NMR spectroscopy) preferred
  • Purity: ≥98% is the accepted bar
  • Heavy metals panel: lead (Pb), arsenic (As), cadmium (Cd), mercury (Hg), all below USP limits (the US Pharmacopeia standard)
  • Microbial counts: within food-grade limits
  • Endotoxin (toxins from bacterial cell walls): optional for oral; required if injectable/IV
  • Third-party lab name: not the manufacturer's own in-house lab

Linked resources. For the NAD+ booster science and the dose ranges used in trials (NMN and NR side by side), see the NAD+ boosters section of the longevity supplements guide. Those doses come from US and Asian trials, not from EU-authorised products.

Frequently asked questions

Is NMN legal in Germany?

Not as a supplement, as of September 2026. NMN is a novel food and needs EU authorisation before anyone may sell it as food [1]. On 11 May 2026, EFSA published a positive safety opinion on EffePharm's NMN (300 mg per day for adults, excluding pregnant and breastfeeding women) [7]. The European Commission has seven months from that opinion to put a draft authorisation to the Member States [1]. Their vote and publication can take longer, and the authorisation will be product-specific. Until it is adopted, selling NMN as a food supplement is not allowed. Many products are labelled "laboratory chemical" or "research use only," which does not make them authorised food. Importing a small amount for personal use is rarely prosecuted, but it is not formally allowed either.

Why is NMN banned in Europe?

Because it is an unauthorised novel food. NMN was not eaten in meaningful amounts in the EU before 15 May 1997, so Regulation (EU) 2015/2283 requires authorisation before anyone may sell it as food or a food supplement [1]. Until that authorisation exists, selling it is not allowed. Calling the product a "laboratory chemical" does not change that. It is not a safety verdict, though. On 11 May 2026 EFSA judged 300 mg a day safe for adults, excluding pregnant and breastfeeding women [7]. European Commission authorisation is the step still outstanding.

Can I buy NMN at a pharmacy, dm or on Amazon?

Not legally as a supplement. Until the European Commission adds NMN to the Union list of novel foods, no shop in Germany may sell it as food or a food supplement [1]. That includes pharmacies, drugstores like dm or Rossmann, and Amazon. Listings you still find are usually labelled "laboratory chemical", which does not make them legal food. If you want a legally sold NAD+ precursor today, nicotinamide riboside (NR) has been authorised since 2020 [2].

Can my doctor prescribe NMN?

NMN is not an approved medicine in Germany. Doctors cannot prescribe it the usual way. Some private longevity doctors may advise on sources or offer NAD+ infusion alternatives. The legal responsibility for sourcing and taking it sits with you.

What's the difference between NMN and NR?

Both are NAD+ precursors. NMN is not the same as NAD+: it is one step before NAD+, and NR is one step before NMN. The biggest practical difference is legal. **NR (nicotinamide riboside) has been EU-authorised as a novel food since 2020** (Regulation 2020/16) and is legally sold as a supplement [2]. NMN is not yet authorised. Their effects on blood NAD+ look similar. Human outcome data is thin for both. NR has a somewhat broader set of human trials: Trammell (2016), Martens (2018), and Dollerup (2018), the last of which was negative on insulin sensitivity [8, 9, 10].

Does NMN actually work?

NMN raises blood NAD+ levels. That part is solid. Whether that translates into measurable health or longevity benefits in humans is less clear. A 2021 trial in Science (Yoshino) showed improved muscle insulin sensitivity in postmenopausal women with prediabetes on 250 mg per day for 10 weeks [5]. A 2022 study (Igarashi) found only nominal gains in gait speed and grip strength in older men [6]. Animal studies show effects on mitochondria (the cell's energy factories) and on metabolism. Large long-term outcome trials with hard endpoints do not exist yet. A 2024 study (Ferrell) also flagged that NAD+ turnover can raise 2PY and 4PY, two breakdown products of vitamin B3 linked in observational data to cardiovascular risk [11]. See our [supplements guide](/en/guide/longevity-supplements) for the closer scientific look.

How much NMN per day is considered safe?

EFSA's 2026 opinion judged 300 mg of NMN a day safe for adults, excluding pregnant and breastfeeding women [7]. That delivers about 110 mg of nicotinamide (a form of vitamin B3). This is roughly five times the daily reference intake for niacin, but well under the 900 mg upper limit [7]. The key human trials used 250 mg a day [5, 6]. Higher doses have no EU safety verdict. This is a safety ceiling, not a dosing recommendation.

Is NMN dangerous or linked to cancer?

In EFSA's 2026 review, NMN raised no genotoxicity concerns (no sign of DNA damage), and the available human study raised no safety concerns [7]. Rats given high doses for 90 days showed effects on reproductive organs, but EFSA judged the safety margin at 300 mg a day sufficient [7]. No study has shown that NMN causes cancer in humans. Cell and mouse studies suggest NAD+ metabolism can also support existing tumours, so with active cancer, talk to your oncology team first.

Will NMN be approved in the EU soon?

Likely for one product, but not yet. EFSA published a positive safety opinion on EffePharm's NMN on 11 May 2026: 300 mg per day is safe for adults, excluding pregnant and breastfeeding women [7]. As of late September 2026 the Commission has not adopted the authorisation. It has seven months from the opinion to put a draft to the Member States, so until about December 2026 [1]. Their vote and publication can take longer. The authorisation will be product-specific. Generic NMN from other producers stays under Novel Food restrictions until each applicant has its own positive opinion and Commission authorisation.

Sources

  1. European Parliament and Council. (2015). Regulation (EU) 2015/2283 on novel foods
  2. European Commission. (2020). Commission Implementing Regulation (EU) 2020/16 authorising nicotinamide riboside chloride as a novel food
  3. Bundesministerium der Justiz / Bundesamt für Justiz. (2024). Heilmittelwerbegesetz (HWG)
  4. US Food and Drug Administration. (2025). Response Letter from FDA HFP to Natural Products Association and Alliance for Natural Health USA (Citizen Petition, Docket FDA-2023-P-0872)
  5. Yoshino M, Yoshino J, Kayser BD, et al. (2021). Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Sciencedoi:10.1126/science.abe9985
  6. Igarashi M, Nakagawa-Nagahama Y, Miura M, et al. (2022). Chronic nicotinamide mononucleotide supplementation elevates blood nicotinamide adenine dinucleotide levels and alters muscle function in healthy older men. npj Agingdoi:10.1038/s41514-022-00084-z
  7. EFSA NDA Panel (Turck D, Bohn T, et al.). (2026). Safety of beta-nicotinamide mononucleotide (β-NMN) pursuant the regulation (EU) 2015/2283 and the bioavailability of nicotinamide from this source in the context of Directive 2002/46/EC. EFSA Journal 24(5)doi:10.2903/j.efsa.2026.10007
  8. Trammell SAJ, Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communicationsdoi:10.1038/ncomms12948
  9. Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communicationsdoi:10.1038/s41467-018-03421-7
  10. Dollerup OL, Christensen B, Svart M, et al. (2018). A randomized placebo-controlled clinical trial of nicotinamide riboside in obese men: safety, insulin-sensitivity, and lipid-mobilizing effects. American Journal of Clinical Nutritiondoi:10.1093/ajcn/nqy132
  11. Ferrell M, Wang Z, Anderson JT, et al. (2024). A terminal metabolite of niacin promotes vascular inflammation and contributes to cardiovascular disease risk. Nature Medicinedoi:10.1038/s41591-023-02793-8
  12. European Parliament and Council. (2006). Regulation (EC) No 1924/2006 on nutrition and health claims made on foods

Questions about longevity rules?

Our local chapters often sit down with doctors, pharmacists, and lawyers to talk through the legal and practical side of longevity products. Join an event near you.

Events near me

Experts in this field

Speakers from the Longevity Germany community on this topic

Related guides

Created by Maurice Lichtenberg, Founder, Longevity Cities

The information provided here is for educational purposes only. Longevity Germany does not provide medical advice, diagnosis, or treatment. Always seek the advice of qualified healthcare providers with questions regarding medical conditions.